AstraZeneca: HµREL® “Superior” for studying low-CLint Compounds. (view summary)
Watch the VideoLeslie Z. Benet, Ph.D. reviews HµREL® multi-species characterization data.
UCB study finds HµRELdogTM “a promising model for chronic studies in metabolism and toxicity”.
Create a Pilot StudyWe offer evaluation kits so researchers can try HµREL®
Call for Academic Research ProposalsHµREL® is pleased to sponsor a program of research grants.